Treatment of electrochemical plating wastewater by heterogeneous photocatalysis: the simultaneous removal of 6:2 fluorotelomer sulfonate and hexavalent chromium

6:2 fluorotelomer sulfonate (6:2 FtS) is being widely used as a mist suppressant in the chromate (Cr(vi)) plating process. As a result, it is often present alongside Cr(vi) in the chromate plating wastewater (CPW). While the removal of Cr(vi) from CPW has been studied for decades, little attention has been paid to the treatment of 6:2 FtS. In this study, the removal of Cr(vi) and 6:2 FtS by Ga₂O₃, In₂O₃, and TiO₂ photocatalysts was investigated. In the Ga₂O₃/UVC system, over 95% of Cr(vi) was reduced into Cr(iii) after only 5 min. Simultaneously, 6:2 FtS was degraded into F⁻ and several perfluorocarboxylates. The predominant reactive species responsible for the degradation of 6:2 FtS in the Ga₂O₃ system were identified to be h_VB⁺ and O₂˙⁻. In addition, it was observed that the presence of Cr(vi) helped accelerate the degradation of 6:2 FtS. This synergy between Cr(vi) and 6:2 FtS was attributable to the scavenging of e_CB⁻ by Cr(vi), which retarded the recombination of e_CB⁻ and h_VB⁺. The In₂O₃/UVC system was also capable of removing Cr(vi) and 6:2 FtS, although at significantly slower rates. In contrast, poor removal of 6:2 FtS was achieved with the TiO₂/UVC system, because Cr(iii) adsorbed on TiO₂ and inhibited its reactivity. Based on the results of this study, it is proposed that CPW can be treated by a treatment train that consists of an oxidation–reduction step driven by Ga₂O₃/UVC, followed by a neutralization step that converts dissolved Cr(iii) into Cr(OH)_3(S).

6:2 fluorotelomer sulfonate (6:2 FtS) and chromate (Cr(vi)) in chromate plating wastewaters can be simultaneously removed by photocatalysis.     

Detection of Helicobacter pylori by enzyme-linked immunosorbent assay of thermophilic helicase-dependent isothermal DNA amplification

An enzyme-linked immunosorbent assay (ELISA) of thermophilic helicase-dependent isothermal DNA amplification (tHDA) was developed for detection of Helicobacter pylori. The primers targeting ureC were used for the amplification of bacterial DNA by the isothermal digoxigenin (DIG)-labeling tHDA process, resulting in the accumulation of DIG-labeled DNA amplicons. The amplicons were denatured using heat and then hybridized with a specific biotinylated DNA probe, which was noncovalently immobilized on streptavidin-coated microtiter plate. The hybrids were colorimetrically detected by the addition of an anti-DIG antibody HRP conjugate and 2,2-azino-di-(3-ethylbenzthiazolinsulfonate) substrate solution. Results obtained from the gastric biopsy samples showed 90% and 95.7% of sensitivity and specificity, respectively, in comparison with culture results, and 96.6% and 96.8% of sensitivity and specificity, respectively, in comparison with those of the histologic studies. This assay significantly reduces the time needed for the identification of H. pylori and has the potential to facilitate early detection of this gastrointestinal pathogen.